At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 33 enrolled
Drug / intervention
BLI400 Laxativedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects
In Brief
A Phase 2 clinical trial evaluating BLI400 Laxative for Constipation. Completed, enrolled 33 participants across 3 sites.
Detailed Summary
The objective of this study is to evaluate the safety and efficacy of BLI400 laxative in constipated adolescent subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConstipation
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartDec 2015
First PostedJan 2016
Primary CompletionApr 2016
TodayJul 2026
First PostedJan 28, 2016
Enrollment StartDec 1, 2015
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.4 years ago
Interventions
BLI400 Laxativedrug